AstraZeneca Plc said on Saturday it signed a contract with European
governments to supply the region with its potential vaccine against the
coronavirus, the British drugmaker’s latest deal to pledge its drug to
help combat the pandemic.
The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, the company said, adding that it was looking to expand manufacturing of the vaccine, which it said it would provide for no profit during the pandemic.
Deliveries will start by the end of 2020.
Read more at:
UPDATE 2-AstraZeneca agrees to supply Europe with 400 mln doses of COVID-19 vaccine - Reuters
The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, the company said, adding that it was looking to expand manufacturing of the vaccine, which it said it would provide for no profit during the pandemic.
Deliveries will start by the end of 2020.
Read more at:
UPDATE 2-AstraZeneca agrees to supply Europe with 400 mln doses of COVID-19 vaccine - Reuters
No comments:
Post a Comment